Main Topics

Gastric cancer immunotherapy is still being explored

Gastric cancer immunotherapy is still an exciting research area, especially the pd-1 inhibitors pembrolizumab (Keytruda) and nivolumab (Nivolumab, Opdivo). In the Phase III ONO-4538-12 trial,...

How did Japan reduce the incidence and death of gastric cancer?

It is not difficult to reduce the mortality rate of gastric cancer in a certain year, but it is difficult to continuously reduce it for 60 years....

How to choose targeted therapy for gastric cancer patients?

Gastric cancer has no good targeted drugs in the past, all relying on cytotoxic drugs that “kill the enemy by a thousand and damage by...

Continuously taking these medicines may double the risk of stomach cancer

A study published in “Intestine” showed that long-term use of proton pump inhibitors will double the risk of gastric cancer . Proton pump inhibitors are a class...

Eating habits that may cause stomach cancer

Related studies have found that patients with gastric cancer have obvious family aggregation: the first-degree relatives (ie parents and siblings) of gastric cancer patients have a three-fold...

D2 radical surgery for gastric cancer or excision of discarded omentum sac

The anterior lobe of the transverse colon and the pancreatic capsule and the serous membrane of the stomach originate from the same germ layer, and...

Nivolumab shows good efficacy in patients with advanced gastric cancer

The recent ONO-4538-12 clinical study released at the ASCO-GI conference showed that compared with placebo, Nivolumab reduced the risk of death of patients by 37%,...

Gastric cancer staging

The following is the stage analysis and conventional treatment plan for gastric cancer published on the American cancer website. TNM staging system for gastric cancer One tool...

New hope for patients with locally advanced gastric cancer

Advanced gastric cancer Gastric cancer has long been in the lead in terms of morbidity and mortality of malignant digestive tract tumors. The biggest reason...

PD-1 combined with chemotherapy is the first-line of treatment for advanced bowel and gastric cancer

Although PD-1 immunotherapy has opened a new model of tumor treatment, and has a good performance in the treatment of non-small cell lung cancer (NSCLC),...

Signals of gastric cancer recurrence and metastasis

Gastric cancer patients Introduction: After clinical treatment of gastric cancer patients, in order to prevent recurrence and metastasis in the rehabilitation process, how can early...

Surgical treatment of gastroesophageal junction tumors

Key points for diagnosis and treatment of tumors at the junction of gastroesophagus 1 Gastroesophageal junction (GEJ) adenocarcinoma occurs at the junction of the esophagus...

Need help? Our team is ready to assist you.

We wish a speedy recovery for your loved ones.

Scan the code